Current Eye Research · 2009 · 53 citations · 20 references
MedicineImmunologyOphthalmologyInflammationInnate ImmunityOcular ImmunologyComplement RegulationImmunopathology Of The EyeMacular DegenerationOcular InflammationRetinal ImmunologyRetinal Pigment EpitheliumComplement ReceptorsComplement-mediated Ocular InflammationComplement-mediated Ocular InjuryNeovascular Macular DegenerationPigment Epithelium-derived FactorReceptors
PURPOSE: We examined the potential for the pro-inflammatory complement proteins C5a and C3a to increase VEGF expression in ARPE-19 cells. MATERIALS AND METHODS: Expression of complement receptors in ARPE-19 cells was evaluated by RT-PCR. VEGF secretion from ARPE-19 cells treated with C5a or C3a was determined by ELISA. RESULTS: C5a and C3a receptor, but not C5L2, were detected in human eye tissue and ARPE-19 cells. C5a, but not C3a, treatment increased VEGF secretion from ARPE-19 cells, an effect inhibited by the C5aR antagonist, NDT 9513727. CONCLUSIONS: C5a receptor mediates increased VEGF secretion from ARPE-19 cells, suggesting a role for the C5a receptor in the pathogenesis of macular degeneration.
20
Gregory S. Hageman, Don H. Anderson, Lincoln V. Johnson et al. · Proceedings of the National Academy of Sciences · 2005 · 2K citations · Full text
Complement C3 Variant and the Risk of Age-Related Macular Degeneration
John R.W. Yates, Tiina Sepp, Baljinder K. Matharu et al. · New England Journal of Medicine · 2007 · 828 citations · Full text
Medicine, Genetics, Ophthalmology +17
Corneal avascularity is due to soluble VEGF receptor-1
Balamurali K. Ambati, Miho Nozaki, Nirbhai Singh et al. · Nature · 2006 · 681 citations · Full text
Medicine, Ophthalmology, Surgery +14